Últimos Artículos de Lancet Diabetes & Endocrinology
- [Correspondence] Association of glycaemic index and glycaemic load with type 2 diabetes, cardiovascular disease, cancer, and all-cause mortality
- [In Focus] Semaglutide: weighing up the benefits and risks
- [Correspondence] Association of glycaemic index and glycaemic load with type 2 diabetes in the PURE study – Authors' reply
- [Comment] The enduring effect of the COVID-19 pandemic on diabetes
- [Articles] Incidence of diabetes after SARS-CoV-2 infection in England and the implications of COVID-19 vaccination: a retrospective cohort study of 16 million people
- [Review] Artificial intelligence for diabetes care: current and future prospects
- [Correspondence] Association of glycaemic index and glycaemic load with type 2 diabetes, cardiovascular disease, cancer, and all-cause mortality – Authors' reply
- [Correspondence] Association of glycaemic index and glycaemic load with type 2 diabetes in the PURE study
- [Editorial] Precision nutrition: a step too far?
- [In Focus] The deep pockets of health-harming industries
- [Comment] SGLT2 inhibitors and GLP-1 receptor agonists: the definitive combination?
- [Articles] Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials
- [Correspondence] Impact of higher BMI on cardiometabolic risk: does height matter?
- [Articles] Once-weekly semaglutide in people with HIV-associated lipohypertrophy: a randomised, double-blind, placebo-controlled phase 2b single-centre clinical trial
- [Comment] Semaglutide in people with HIV-associated lipohypertrophy
- [Viewpoint] The potential role for artificial intelligence in fracture risk prediction
- [Comment] Value of early pregnancy HbA1c to predict gestational diabetes
- [Articles] Early pregnancy HbA1c as the first screening test for gestational diabetes: results from three prospective cohorts
- [Correspondence] An integrated diabetes and mental health intervention for people with type 1 diabetes and severe disordered eating: a prospective proof-of-concept cohort study
- [Comment] Call for effective therapies for preventing dementia in people with type 2 diabetes